Giuseppe Bellelli1, Andrea Mazzone2, Alessandro Morandi3, Nicola Latronico4, Sabrina Perego5, Sara Zazzetta5, Paolo Mazzola5, Giorgio Annoni6. 1. Department of Health Sciences, University of Milano-Bicocca, Monza, Italy; Geriatric Unit, S. Gerardo Hospital, Monza, Italy; Geriatric Research Group, Brescia, Italy. Electronic address: giuseppe.bellelli@unimib.it. 2. Department of Rehabilitation, Redaelli Geriatric Institute, Milan, Italy. 3. Geriatric Research Group, Brescia, Italy; Department of Rehabilitation and Aged Care "Fondazione Camplani" Hospital, Cremona, Italy. 4. Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy; Department of Anesthesia, Critical Care and Emergency, Spedali Civili University Hospital, Brescia, Italy. 5. Department of Health Sciences, University of Milano-Bicocca, Monza, Italy. 6. Department of Health Sciences, University of Milano-Bicocca, Monza, Italy; Geriatric Unit, S. Gerardo Hospital, Monza, Italy.
Abstract
OBJECTIVE: Impaired arousal is associated with negative outcomes in intensive care units, but studies in acute medical wards are scanty. The study aim was to evaluate the association between impaired arousal, as measured using an ultrabrief screen, and risk of both 1- and 6-month mortality and discharge to nursing home (NH) or hospice. DESIGN: Prospective cohort study with 6-month follow-up. SETTING: An acute geriatric unit (AGU) of a university-based hospital in Northern Italy. PARTICIPANTS: All patients aged 65 years or older, admitted to the AGU between September 2012 and February 2015. MEASUREMENTS: The modified Richmond Agitation Sedation Scale (m-RASS) was used to assess patients' arousal; a score of 0 denotes normal arousal, scores ranging from +1 to +4 denote increased arousal, and scores ranging from -1 to -5 denote decreased levels. The association of m-RASS scores with 6-month mortality was assessed by a Kaplan-Meier analysis. The impact of impaired arousal, defined by the m-RASS as anything other than "awake and alert," was determined using Cox proportional hazard regression for 1- and 6-month mortality after admission and logistic regressions were used for discharge to NH or hospice. The models were adjusted for age, sex, dementia, Sequential Organ Failure Assessment score, and disability. RESULTS: Patients (n = 2477) had a mean age of 84 years, and were predominantly women (59.8%). Impaired arousal on admission was present in 644 (25.9%) patients: 33 (1.3%) were comatose (m-RASS = -5), 56 (2.3%) awakened to pain only (m-RASS = -4), 43 (1.7%) were very drowsy (m-RASS = -3), 93 (3.8%) drowsy (m-RASS = -2), and 212 (8.6%) were slightly drowsy (m-RASS = -1), but there were also 110 (4.4%) patients with restlessness, 75 (3.0%) with agitation, 17 (0.7%) with severe agitation, and 3 (0.1%) with combative behavior. Globally, 337 patients died within 1 month and 689 patients within 6 months. After adjustment for covariates, patients with impaired arousal had a significantly higher chance of having died at 1-month (adjusted hazard ratio [HR] 1.56, 95% confidence interval [CI] 1.22-2.03) and 6-month follow-up (adjusted HR 1.31, 95% CI 1.10-1.57). Those with impaired arousal were more likely to be discharged to a new NH (odds ratio [OR] 1.75, 95% CI 1.19-2.57) or to hospice (OR 1.96, 95% CI 1.18-3.23) than those without impaired arousal. CONCLUSIONS: An abnormal arousal level is an independent predictor of increased risk of 1- and 6-month mortality and of discharge to a new NH or hospice. The assessment of arousal with m-RASS should be routinely performed on all older patients on admission to acute hospital wards to screen potentially critical conditions.
OBJECTIVE: Impaired arousal is associated with negative outcomes in intensive care units, but studies in acute medical wards are scanty. The study aim was to evaluate the association between impaired arousal, as measured using an ultrabrief screen, and risk of both 1- and 6-month mortality and discharge to nursing home (NH) or hospice. DESIGN: Prospective cohort study with 6-month follow-up. SETTING: An acute geriatric unit (AGU) of a university-based hospital in Northern Italy. PARTICIPANTS: All patients aged 65 years or older, admitted to the AGU between September 2012 and February 2015. MEASUREMENTS: The modified Richmond Agitation Sedation Scale (m-RASS) was used to assess patients' arousal; a score of 0 denotes normal arousal, scores ranging from +1 to +4 denote increased arousal, and scores ranging from -1 to -5 denote decreased levels. The association of m-RASS scores with 6-month mortality was assessed by a Kaplan-Meier analysis. The impact of impaired arousal, defined by the m-RASS as anything other than "awake and alert," was determined using Cox proportional hazard regression for 1- and 6-month mortality after admission and logistic regressions were used for discharge to NH or hospice. The models were adjusted for age, sex, dementia, Sequential Organ Failure Assessment score, and disability. RESULTS:Patients (n = 2477) had a mean age of 84 years, and were predominantly women (59.8%). Impaired arousal on admission was present in 644 (25.9%) patients: 33 (1.3%) were comatose (m-RASS = -5), 56 (2.3%) awakened to pain only (m-RASS = -4), 43 (1.7%) were very drowsy (m-RASS = -3), 93 (3.8%) drowsy (m-RASS = -2), and 212 (8.6%) were slightly drowsy (m-RASS = -1), but there were also 110 (4.4%) patients with restlessness, 75 (3.0%) with agitation, 17 (0.7%) with severe agitation, and 3 (0.1%) with combative behavior. Globally, 337 patients died within 1 month and 689 patients within 6 months. After adjustment for covariates, patients with impaired arousal had a significantly higher chance of having died at 1-month (adjusted hazard ratio [HR] 1.56, 95% confidence interval [CI] 1.22-2.03) and 6-month follow-up (adjusted HR 1.31, 95% CI 1.10-1.57). Those with impaired arousal were more likely to be discharged to a new NH (odds ratio [OR] 1.75, 95% CI 1.19-2.57) or to hospice (OR 1.96, 95% CI 1.18-3.23) than those without impaired arousal. CONCLUSIONS: An abnormal arousal level is an independent predictor of increased risk of 1- and 6-month mortality and of discharge to a new NH or hospice. The assessment of arousal with m-RASS should be routinely performed on all older patients on admission to acute hospital wards to screen potentially critical conditions.
Authors: Susan D Shenkin; Christopher Fox; Mary Godfrey; Najma Siddiqi; Steve Goodacre; John Young; Atul Anand; Alasdair Gray; Janet Hanley; Allan MacRaild; Jill Steven; Polly L Black; Zoë Tieges; Julia Boyd; Jacqueline Stephen; Christopher J Weir; Alasdair M J MacLullich Journal: BMC Med Date: 2019-07-24 Impact factor: 8.775
Authors: Ryan A Tesh; Haoqi Sun; Jin Jing; Mike Westmeijer; Anudeepthi Neelagiri; Subapriya Rajan; Parimala V Krishnamurthy; Pooja Sikka; Syed A Quadri; Michael J Leone; Luis Paixao; Ezhil Panneerselvam; Christine Eckhardt; Aaron F Struck; Peter W Kaplan; Oluwaseun Akeju; Daniel Jones; Eyal Y Kimchi; M Brandon Westover Journal: Crit Care Explor Date: 2022-01-18
Authors: Amy Todd; Samantha Blackley; Jennifer K Burton; David J Stott; E Wesley Ely; Zoë Tieges; Alasdair M J MacLullich; Susan D Shenkin Journal: BMC Geriatr Date: 2017-12-08 Impact factor: 3.921
Authors: Alessandro Morandi; Jin H Han; David Meagher; Eduard Vasilevskis; Joaquim Cerejeira; Wolfgang Hasemann; Alasdair M J MacLullich; Giorgio Annoni; Marco Trabucchi; Giuseppe Bellelli Journal: J Am Med Dir Assoc Date: 2016-06-23 Impact factor: 4.669